In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and Pfizer ...

Read on to learn why. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter investments with weekly expert stock picks from the ...

Franklin Resources trimmed its Pfizer stake by a smidge, selling just 25,315 shares—but when you’ve got over 16 million, ...

We put performance trends for stocks, sectors, bonds, and funds into perspective, and offer outlooks for the next quarter.

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

StoneX Group clearly didn’t skip leg day—it just bulked up its Pfizer holdings by a massive 43.5% in Q4, scooping up over ...

IDEAYA Biosciences, Inc.’s IDYA share price has surged by 10.70%, which has investors questioning if this is right time to sell.

Discover 10 top high-yield dividend stocks for April 2025. With a 5.30% yield & 8.33% growth rate, learn how to build wealth ...

The latest trading session saw Pfizer (PFE) ending at $24.70, denoting a +0.65% adjustment from its last day's close. This change lagged the S&P 500's 0.67% gain on the day. Meanwhile, the Dow ...

Nucor Corp, Crude Oil WTI Futures, Natural Gas Futures, Weyerhaeuser Company. Read 's Market Analysis on Investing.com ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE – Research Report), Nanobiotix (NBTX – Research ...